<DOC>
	<DOCNO>NCT02746575</DOCNO>
	<brief_summary>Perioperative cardiac adverse event [ heart injury cause general anesthesia surgical procedure ] significant public health issue , 60,000 death per annum patient surgery non-heart related issue . There virtually evidence-based medical strategy effective prevention event . Preoperative drug treatment beta blockade drug use high blood pressure , perioperative therapy lipid lower drug statin , alpha-receptor agonist clonidine use high blood pressure , aspirin investigate potential mitigating treatment , without positive clinical outcome , case , create hemodynamic instability result heart injury . In light , investigator propose evaluate safety efficacy use increase dos beta blockade drug immediately surgery assess value high-sensitivity cardiac troponin level test blood predicting patient would benefit perioperative beta blocker therapy .</brief_summary>
	<brief_title>Pilot - Peri-operative Beta Blockade</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Age &gt; 50 year American Society Anesthesiologists ( ASA ) risk status IIIIV Revised Cardiac Risk Index ≥2 βblocker naïve ( receive βblocker within 30 day prior surgery ) Previously diagnose coronary artery disease ( CAD ) high risk CAD : History peripheral vascular disease , Diabetes currently oral antidiabetic drug insulin therapy , Chronic renal failure ( eGFR &lt; 30 m/min ) Major noncardiac surgery general anesthesia History stroke Heart rate &lt; 55bpm Heart failure Second third degree AV block without pacemaker Active asthma COPD Anemia [ Hb &lt; 9g/dL ] Allergy betablockade drug Hemodynamic instability Uncontrolled hemorrhage Unwilling unable give consent participation</criteria>
	<gender>All</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>